Delivery Order SPE2DB22D3004-SPE2DB25FRS85
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count units) valued at $3,328.77. This firm fixed-price delivery order is set to be completed by July 31, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a non-competitive delivery against AmerisourceBergen's larger indefinite delivery contract with DLA. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $7,909.49 to AmerisourceBergen Drug Corp on July 1, 2025, for the supply of Janumet XR 50-1,000 mg tablets in quantities of 60 units. The contract is a firm fixed price delivery order with an ultimate completion date of July 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was used in this competitive award. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count packages) valued at $3,508.43. This contract utilizes a firm fixed-price structure with an ultimate completion date of September 26, 2025, and was awarded on a competitive basis without any set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,374.12 to AmerisourceBergen Drug Corp for the supply of Janumet XR 50-500 mg tablets (180-count unit) on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger federal contracting relationship with DLA. The place of performance is located at the contractor's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Janumet 50-1,000 mg tablets (180 count) with a contract ceiling value of $4,393.68. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for ultimate completion on July 23, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order represents a...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of JANUMET XR 50-1,000 mg tablets (180-count units). This firm fixed-price delivery order, valued at $29,236.05, represents a competitive award with no set-aside designation and a completion date of June 20, 2025. The contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count units) with a ceiling value of $1,991.88. This is a firm fixed-price delivery order issued without a set-aside designation, indicating competitive award eligibility. The product will be delivered to the company's place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of August 26, 2025. AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $2,528.28 to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Janumet XR 50-1,000 mg tablets in a quantity of 180 units. This competitively awarded, non-set-aside contract involves firm fixed pricing and is scheduled for completion by September 2, 2025. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count) with a contract value of $3,046.18. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on August 26, 2025. The contract calls for the delivery of 180-count bottles of Janumet XR 50-1,000 mg tablets with a ceiling value of $4,186.29 under a firm fixed price arrangement. The award is non-set-aside and represents a competitive delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FRS85Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count units) with a ceiling value of $2,511.68. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 1, 2025. As a child contract under AmerisourceBergen's broader contract portfolio, this order represents a routine pharmaceutical procurement fulfilling military healthcare supply needs. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime vendor contract serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of medications and medical supplies to support military healthcare programs worldwide. The company's federal contract awards demonstrate consistent capability in fulfilling competitive pharmaceutical procurement requirements across multiple therapeutic domains for the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 7/31/25 |